ArticleInflammatory bowel diseases2024
Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease.
Elizabeth A Spencer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
30 papers cite it
this paperpooled itcites it